Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal topical azithromycin plus oral azithromycin for cutaneous leishmaniasis
IRCT20180425039414N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cutaneous leishmaniasis (CL) comparing Oral azithromycin + topical liposomal azithromycin with Oral azithromycin + topical placebo (2 arms). Primary endpoints: Lesion size and Azithromycin complications. Started Sep 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20180425039414N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180425039414N1.